Cargando…

The 2-alkyl-2H-indazole regioisomers of synthetic cannabinoids AB-CHMINACA, AB-FUBINACA, AB-PINACA, and 5F-AB-PINACA are possible manufacturing impurities with cannabimimetic activities

Indazole-derived synthetic cannabinoids (SCs) featuring an alkyl substituent at the 1-position and l-valinamide at the 3-carboxamide position (e.g., AB-CHMINACA) have been identified by forensic chemists around the world, and are associated with serious adverse health effects. Regioisomerism is poss...

Descripción completa

Detalles Bibliográficos
Autores principales:	Longworth, Mitchell, Banister, Samuel D., Mack, James B. C., Glass, Michelle, Connor, Mark, Kassiou, Michael
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Japan 2016
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4971050/ https://www.ncbi.nlm.nih.gov/pubmed/27547266 http://dx.doi.org/10.1007/s11419-016-0316-y

Ejemplares similares

Detection of the Synthetic Cannabinoids AB-CHMINACA, ADB-CHMINACA, MDMB-CHMICA, and 5F-MDMB-PINACA in Biological Matrices: A Systematic Review
por: Navarro-Tapia, Elisabet, et al.
Publicado: (2022)

Inhibitory Effect of AB-PINACA, Indazole Carboxamide Synthetic Cannabinoid, on Human Major Drug-Metabolizing Enzymes and Transporters
por: Park, Eun Jeong, et al.
Publicado: (2020)

Off-target pharmacological profiling of synthetic cannabinoid receptor agonists including AMB-FUBINACA, CUMYL-PINACA, PB-22, and XLR-11
por: Kevin, Richard C., et al.
Publicado: (2022)

Atypical Pharmacodynamic Properties and Metabolic Profile of the Abused Synthetic Cannabinoid AB-PINACA: Potential Contribution to Pronounced Adverse Effects Relative to Δ(9)-THC
por: Hutchison, Rachel D., et al.
Publicado: (2018)

Four types of cannabimimetic indazole and indole derivatives, ADB-BINACA, AB-FUBICA, ADB-FUBICA, and AB-BICA, identified as new psychoactive substances
por: Qian, Zhenhua, et al.
Publicado: (2015)

The short-acting synthetic cannabinoid AB-FUBINACA induces physical dependence in mice
por: Trexler, Kristen R., et al.
Publicado: (2020)

Detection and Characterization of the Effect of AB‐FUBINACA and Its Metabolites in a Rat Model
por: Hsin‐Hung Chen, Michael, et al.
Publicado: (2015)

5F-Cumyl-PINACA in ‘e-liquids’ for electronic cigarettes: comprehensive characterization of a new type of synthetic cannabinoid in a trendy product including investigations on the in vitro and in vivo phase I metabolism of 5F-Cumyl-PINACA and its non-fluorinated analog Cumyl-PINACA
por: Angerer, Verena, et al.
Publicado: (2018)

Heroin Adulterated with the Novel Synthetic Cannabinoid, 5F-MDMB-PINACA: A Case Series
por: Ershad, Muhammed, et al.
Publicado: (2020)

Motor vehicle collisions caused by the ‘super-strength’ synthetic cannabinoids, MAM-2201, 5F-PB-22, 5F-AB-PINACA, 5F-AMB and 5F-ADB in Japan experienced from 2012 to 2014
por: Kaneko, Shuji
Publicado: (2017)

A synthetic cannabinoid FDU-NNEI, two 2H-indazole isomers of synthetic cannabinoids AB-CHMINACA and NNEI indazole analog (MN-18), a phenethylamine derivative N–OH-EDMA, and a cathinone derivative dimethoxy-α-PHP, newly identified in illegal products
por: Uchiyama, Nahoko, et al.
Publicado: (2015)

In Vitro Interaction of AB-FUBINACA with Human Cytochrome P450, UDP-Glucuronosyltransferase Enzymes and Drug Transporters
por: Kim, Sunjoo, et al.
Publicado: (2020)

Psychologisches Privatattest über Ehepartner als Datenschutzverstoß: DSGVO Art. 9 Abs. 1–3, 15 Abs. 3 und 4, 17, 79 Abs. 1, 82 Abs. 1; BGB §§362 Abs. 1, 823 Abs. 1, 1004 Abs. 1 S. 2; StGB §203 Abs. 1 Nr. 2
Publicado: (2023)

What is ABS?
por: Autin, Bruno, et al.
Publicado: (1999)

ABS at CRYRING
por: Simonsson, A, et al.
Publicado: (1999)

Fatal Overdose with the Cannabinoid Receptor Agonists MDMB-4en-PINACA and 4F-ABUTINACA: A Case Report and Review of the Literature
por: Simon, Gábor, et al.
Publicado: (2023)

Rechtmäßigkeit der Einführung einer Duldungspflicht für Covid-19-Impfungen bei Soldaten: GG Art. 2 Abs. 1, Art. 2 Abs. 2, Art. 12 Abs. 1, Art. 33 Abs. 4, Art. 87a; SG §§10 Abs. IV, 17a Abs. 1, Abs. 2 S. 1 Nr. 1, Abs. 4
Publicado: (2023)

Investigation of Fatigue Behavior of ABS and PC-ABS Polymers at Different Temperatures
por: Mura, Andrea, et al.
Publicado: (2018)

Informationspflicht und Traumaverarbeitung: BGB 278, 280 Abs. 1, 630a Abs. 1, 630c Abs. 2 S. 2, 630h Abs. 5 S. 1
Publicado: (2022)

Cytotoxicity, metabolism, and isozyme mapping of the synthetic cannabinoids JWH-200, A-796260, and 5F-EMB-PINACA studied by means of in vitro systems
por: Gampfer, Tanja M., et al.
Publicado: (2021)

Analytical findings in a non-fatal intoxication with the synthetic cannabinoid 5F-ADB (5F-MDMB-PINACA): a case report
por: Gaunitz, Franziska, et al.
Publicado: (2021)

Der Anspruch auf eine Covid-19-Zweitimpfung: GG Art. 1 Abs. 1, Art. 2 Abs. 2, Art. 3 Abs. 1, Art. 20 Abs. 3; VwGO §123 Abs. 1 S. 2; VwVfG §38 Abs. 1
Publicado: (2022)

Voraussetzungen einer Sonderbedarfsfeststellung: GG Art. 12 Abs. 1; SGB V 95 Abs. 2, 101 Abs. 1 S. 1 Nr. 3, 285 Abs. 1, Abs. 3 S. 1; BedarfsplanungsRL 36, 37; DSGVO Art. 6 Abs. 1 und 2
Publicado: (2021)

Impact of PP Impurities on ABS Tensile Properties: Computational Mechanical Modelling Aspects
por: Signoret, Charles, et al.
Publicado: (2021)

Ab Interno Trabeculectomy
por: Pantcheva, Mina B., et al.
Publicado: (2010)

ABS at the PS division
por: Martini, M
Publicado: (1999)

ABS at the SPS and LEP
por: Wenninger, J
Publicado: (1999)

ABS at CTF3
por: Braun, H
Publicado: (1999)

The AB Staff Plan
por: Boillot, J, et al.
Publicado: (2003)

Erythema ab igne
por: Treister-Goltzman, Yulia, et al.
Publicado: (2015)

Betaferon® – Ab Ovo
por: Limmroth, Volker
Publicado: (2013)

Abstract No. : ABS2211
por: Raja, Thanigai
Publicado: (2022)

AB077. Relationship of TPO-Ab and TSH with in vitro fertilization and embryo transfer
por: Wang, Liyun
Publicado: (2015)

HBsAb and HBcAb Have No Significant Effect on the Progression of SLE and RA
por: WANG, Fen, et al.
Publicado: (2017)

SEPPA-mAb: spatial epitope prediction of protein antigens for mAbs
por: Qiu, Tianyi, et al.
Publicado: (2023)

SARS-CoV-2-Specific Antibody (Ab) Levels and the Kinetic of Ab Decline Determine Ab Persistence Over 1 Year
por: Garner-Spitzer, Erika, et al.
Publicado: (2022)

Keine Berücksichtigung von Konzeptbewerbungen eines MVZ ohne Benennung des anzustellenden Arztes : GG Art. 12 Abs. 1, 20 Abs. 2 S. 2; SGB V v 21.12.1992 §§92 Abs. 1 S. 2 Nr. 9, 95 Abs. 2, 95 Abs. 9, 101 Abs. 1 S. 1, 103 Abs. 3; SGB V v. 16.7.2015 §103 Abs. 4 S. 10, SGB V v. 6.5.2019 §103 Abs. 4 S. 5 Nr. 9; Ärzte-ZV §§1 Abs. 3 Nr. 2, 16b Abs. 3 Ärzte-ZV, 18 Ärzte-ZV, 32b Abs. 2; ÄBedarfsplRL §26; SGG §75 Abs. 2
Publicado: (2020)

Correction to: Analytical findings in a non-fatal intoxication with the synthetic cannabinoid 5F-ADB (5F-MDMB-PINACA): a case report
por: Gaunitz, Franziska, et al.
Publicado: (2022)

Teilnahme am Regelunterricht (Präsenzunterricht) in der Schule ohne Mund-Nasen-Bedeckung: GG Art. 2 Abs. 1 u. 2, 19 Abs. 4; VwGO 80 Abs. 5,123 Abs. 1 S. 2; ZPO 920 Abs. 2 ZPO, 294; IfSG 32 S. 1 u. 2, 28a Abs. 1 S. 1; Nds. Corona-Verordnung 3 Abs. 6, 13 Abs. 1 S. 4ff.; NSchG 31 Abs. 1, Abs. 10 Nr. 1 lit. h).
Publicado: (2022)

Arbeitnehmereigenschaft des Praxisvertreters: BGB §611a Abs. 1; ArbGG §§2 Abs. 1 Nr. 3, 5 Abs. 1
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_mu2v8hjv4vn6prqnnukn2rf74a